On December 7, 2020, Jack W. Reich, Ph.D. agreed to join Adial Pharmaceuticals, Inc. as the Company's full-time Head of Regulatory, effective December 14, 2020. As part of this transition to Company management, Dr. Reich notified the Board of Directors of the Company of his intention to resign as a member of the Board, also effective December 14, 2020. Dr. Reich's resignation from the Board was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.